Literature DB >> 19720283

Reproducibility of the kinetic analysis of 3'-deoxy-3'-[(18)F]fluorothymidine positron emission tomography in mouse tumor models.

Seung Jin Choi1, Seog Young Kim, Su Jin Kim, Jae Sung Lee, Sang Ju Lee, Soo Ah Park, Seung Jin Lee, Sung-Cheol Yun, Ki Chun Im, Seung Jun Oh, Sang-We Kim, Jae Seung Kim, Jin Sook Ryu, Dae Hyuk Moon.   

Abstract

OBJECTIVES: We assessed the reproducibility of the kinetic analysis of 3'-deoxy-3'-[(18)F]fluorothymidine (FLT) positron emission tomography (PET) in A431 human epidermoid carcinoma and murine Lewis lung carcinoma (LLC) tumor models.
METHODS: We injected 7.4 MBq of FLT (n=10 for each group) and acquired 2-h dynamic PET images. A second scan was performed 1 day later. We calculated standardized uptake value (SUV), kinetic rate constants, volume of distribution of phosphorylated FLT (V(dm)), net influx constant (K(FLT-CA)) and influx constant by Patlak graphical analysis (K(FLT-PA)). The percent difference between measurements of a parameter was calculated to compare the reproducibilities of different parameters.
RESULTS: FLT phosphorylation was higher in mice with A431 tumors than in mice with LLC tumors (P<.005). Differences in the standard deviations of the percent differences of parameters were statistically significant (P<.001) in each model. In mice with A431 tumors, SUV, V(dm), K(FLT-CA) and K(FLT-PA) had standard deviations of the percent difference of < or = 20%. The most reproducible parameter was K(FLT-PA), although the standard deviation (15.6%) was not statistically different from those of V(dm) (15.8%), K(FLT-CA) (17.5%) and SUV (18.9%). In mice with LLC tumors, K(1), K(1)/k(2) and k(3) had standard deviations of the percent difference of < or = 20%. No macroparameters reflecting a total FLT flux had standard deviations of < or = 20%.
CONCLUSION: Our results show the reproducibility of the kinetic macroparameters of FLT PET in mouse tumors with high FLT phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19720283     DOI: 10.1016/j.nucmedbio.2009.06.001

Source DB:  PubMed          Journal:  Nucl Med Biol        ISSN: 0969-8051            Impact factor:   2.408


  3 in total

1.  Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.

Authors:  Jennifer G Whisenant; Todd E Peterson; Jacob U Fluckiger; Mohammed Noor Tantawy; Gregory D Ayers; Thomas E Yankeelov
Journal:  Mol Imaging Biol       Date:  2013-02       Impact factor: 3.488

2.  Early assessment of tumor response to JAC106, an anti-tubulin agent, by 3'-deoxy-3'-[¹⁸F]fluorothymidine in preclinical tumor models.

Authors:  Seung Jin Lee; Hye Young Kang; Seog Young Kim; Jin Hwa Chung; Seung Jun Oh; Jin-Sook Ryu; Sung-Bae Kim; Jong Soon Kang; Song-Kyu Park; Hwan Mook Kim; Myung-Hwa Kim; Dae Hyuk Moon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-12       Impact factor: 9.236

3.  P-glycoprotein at the blood-brain barrier: kinetic modeling of 11C-desmethylloperamide in mice using a 18F-FDG μPET scan to determine the input function.

Authors:  Lieselotte Moerman; Dieter De Naeyer; Paul Boon; Filip De Vos
Journal:  EJNMMI Res       Date:  2011-07-29       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.